| | 1320288-19-4 Basic information More.. |
| Product Name: | UNC 0631 | | Synonyms: | UNC 0631, >=98%;N-(1-(cyclohexylmethyl)piperidin-4-
yl)-2-(4-isopropyl-1,4-diazepan-1-yl)-
6-methoxy-7-(3-(piperidin-1-
yl)propoxy)quinazolin-4-amine;UNC 0631;UNC0631/UNC-0631;N-[1-(CyclohexylMethyl)-4-piperidinyl]-2-[hexahydro-4-(1-Methylethyl)-1H-1,4-diazepin-1-yl]-6-Methoxy-7-[3-(1-piperidinyl)propoxy]-4-quinazolinaMine;N-[1-(Cyclohexylmethyl)-4-piperidinyl]-2-[hexahydro-4-(1-methylethyl)-1H-1,4-diazepin-1-yl]-6-methoxy-7-[3-(1-piperidinyl)propoxy]-4-quinazolinamine UNC0631;N-[1-(Cyclohexylmethyl)-4-piperidinyl]-2-(4-isopropyl-1,4-diazepa n-1-yl)-6-methoxy-7-[3-(1-piperidinyl)propoxy]-4-quinazolinamine;CS-793 | | CAS: | 1320288-19-4 | | MF: | C37H61N7O2 | | MW: | 635.93 | | EINECS: | 604-604-1 | | Mol File: | 1320288-19-4.mol |  |
Use
UNC0631 is a potent and selective inhibitor of G9a activity in vitro (IC50 = 4 nM) and G9a/GLP-mediated dimethylation of histone 3 on lysine 9 in MDA-MB-231 cells (IC50 = 25 nM). It potently inhibits G9a/GLP activity in a variety of cancer cell lines as well as in the human fetal lung IMR-90 cell line.[Cayman Chemical]
- UNC 0631
-
- US $42.00-156.00 / mg
- 2025-05-16
- CAS:1320288-19-4
- Min. Order:
- Purity: 99.92%
- Supply Ability: 10g
- UNC 0631
-
- US $0.01 / KG
- 2024-10-22
- CAS:1320288-19-4
- Min. Order: 1KG
- Purity: 95%-99%
- Supply Ability: 1kg; 5kg; 10kg
|
|
1320288-19-4
Recommend Suppliers |
|